• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素释放激素(TRH)在人血浆中的降解动力学及模式

Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

作者信息

Møss J, Bundgaard H

机构信息

Royal Danish School of Pharmacy, Department of Pharmaceutical Chemistry, Copenhagen, Denmark.

出版信息

Pharm Res. 1990 Jul;7(7):751-5. doi: 10.1023/a:1015875824238.

DOI:10.1023/a:1015875824238
PMID:2118634
Abstract

The kinetics and mechanism of degradation of the tripeptide TRH (pGlu-His-Pro-NH2) and its various primary and secondary degradation products (TRH-OH, His-Pro-NH2, and His-Pro) have been determined in human plasma at 37 degrees C. The rates of degradation of both TRH and TRH-OH (pGlu-His-Pro) showed mixed zero-order and first-order kinetics. At low substrate concentrations first-order kinetics occurred, with TRH and TRH-OH degradation half-lives of 9.4 and 27 min, respectively. The initial step in the plasma-catalyzed degradation of TRH is due to hydrolysis of the pGlu-His bond by the TRH-specific pyroglutamyl aminopeptidase serum enzyme, resulting in the exclusive formation of histidyl-proline amide (His-Pro-NH2). Using specific HPLC methods the major degradation route (67%) of this dipeptide in human plasma was hydrolysis of the peptide bond to yield His and Pro-NH2, whereas deamidation to yield His-Pro accounted for 29% of the total degradation. A minor pathway (less than or equal to 4%) was spontaneous cyclization to yield cyclo(His-Pro). Both His-Pro-NH2 and His-Pro degraded by first-order kinetics and faster than TRH, with half-lives of 5.3 and 2.2 min, respectively, in 80% plasma.

摘要

已在37℃的人血浆中测定了三肽TRH(焦谷氨酸-组氨酸-脯氨酸-酰胺)及其各种一级和二级降解产物(TRH-OH、组氨酸-脯氨酸-酰胺和组氨酸-脯氨酸)的降解动力学和机制。TRH和TRH-OH(焦谷氨酸-组氨酸-脯氨酸)的降解速率均呈现零级和一级混合动力学。在低底物浓度下发生一级动力学,TRH和TRH-OH的降解半衰期分别为9.4分钟和27分钟。血浆催化TRH降解的初始步骤是由TRH特异性焦谷氨酸氨肽酶血清酶水解焦谷氨酸-组氨酸键,导致唯一形成组氨酰-脯氨酸酰胺(组氨酸-脯氨酸-酰胺)。使用特定的高效液相色谱方法,该二肽在人血浆中的主要降解途径(67%)是肽键水解产生组氨酸和脯氨酸酰胺,而脱酰胺产生组氨酸-脯氨酸占总降解的29%。一条次要途径(小于或等于4%)是自发环化产生环(组氨酸-脯氨酸)。组氨酸-脯氨酸-酰胺和组氨酸-脯氨酸均通过一级动力学降解,且比TRH降解得更快,在80%血浆中的半衰期分别为5.3分钟和2.2分钟。

相似文献

1
Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.促甲状腺激素释放激素(TRH)在人血浆中的降解动力学及模式
Pharm Res. 1990 Jul;7(7):751-5. doi: 10.1023/a:1015875824238.
2
A radioimmunoassay for the measurement of pyroglutamyl-histidyl-proline, a proposed thyrotropin releasing hormone metabolite.一种用于测量焦谷氨酸-组氨酸-脯氨酸(一种假定的促甲状腺激素释放激素代谢物)的放射免疫测定法。
J Clin Endocrinol Metab. 1975 Apr;40(4):742-5. doi: 10.1210/jcem-40-4-742.
3
High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
J Clin Endocrinol Metab. 1996 Aug;81(8):2816-20. doi: 10.1210/jcem.81.8.8768836.
4
Characterization of a circulating N-extended form of the thyrotropin-releasing hormone-like peptide pGlu-Glu-Pro amide in human plasma.
J Clin Endocrinol Metab. 2003 Dec;88(12):6002-7. doi: 10.1210/jc.2003-030681.
5
Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans.人促甲状腺激素释放激素样肽焦谷氨酰-谷氨酰-脯氨酰胺的肾清除率
J Clin Endocrinol Metab. 1997 Sep;82(9):3068-73. doi: 10.1210/jcem.82.9.4219.
6
Urinary excretion of the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in rats.大鼠中促甲状腺激素释放激素样肽焦谷氨酰-谷氨酰-脯氨酰胺的尿排泄情况。
J Endocrinol. 1997 Jun;153(3):411-21. doi: 10.1677/joe.0.1530411.
7
Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.促甲状腺激素释放激素(TRH)前体TRH-Gly对促甲状腺激素和催乳素的释放作用:转化为TRH足以产生体内效应。
Neuroendocrinology. 1990 Dec;52(6):618-25. doi: 10.1159/000125654.
8
In vitro production of a TRH-homologous peptide and His-Pro diketopiperazine by human semen.
J Androl. 1985 Nov-Dec;6(6):379-85. doi: 10.1002/j.1939-4640.1985.tb03298.x.
9
Characteristics of the plasma TRH-degrading enzyme.
Neuroendocrinology. 1975;19(3):277-87.
10
Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide.外源性促甲状腺激素释放激素及焦谷氨酸-N3-甲基-组氨酰-脯氨酰胺的血浆清除率和血浆半衰期。
J Clin Endocrinol Metab. 1979 Mar;48(3):377-80. doi: 10.1210/jcem-48-3-377.

引用本文的文献

1
Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.布氏锥虫的I型焦谷氨酸肽酶:一种来自非洲锥虫的新毒力因子,可解除感染宿主血浆中调节肽的封闭状态。
Biochem J. 2006 Mar 15;394(Pt 3):635-45. doi: 10.1042/BJ20051593.
2
Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?促甲状腺激素释放激素(TRH)在人肠细胞系(Caco-2)单层中的跨上皮转运与代谢:主动转运成分的证据?
Pharm Res. 1994 Nov;11(11):1575-80. doi: 10.1023/a:1018953603301.
3

本文引用的文献

1
The purification and characterization of a proline dipeptidase from guinea pig brain.豚鼠脑脯氨酸二肽酶的纯化与特性分析
J Biol Chem. 1983 May 25;258(10):6147-54.
2
Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation.作为新药来源的调节肽——耐代谢降解的促甲状腺激素释放激素类似物的临床前景。
Brain Res. 1982 Nov;257(3):389-408. doi: 10.1016/0165-0173(82)90012-1.
3
Thyrotropin-releasing hormone metabolism in visceral organ homogenates of the rat.
Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.
肽的前药。6. 促甲状腺激素释放激素(TRH)的生物可逆衍生物,具有增加的亲脂性和对TRH特异性血清酶裂解的抗性。
Pharm Res. 1990 Sep;7(9):885-92. doi: 10.1023/a:1015933504191.
Endocrinology. 1982 Jun;110(6):2101-6. doi: 10.1210/endo-110-6-2101.
4
Thyrotropin-releasing hormone.促甲状腺激素释放激素
N Engl J Med. 1982 Jan 21;306(3):145-55. doi: 10.1056/NEJM198201213060305.
5
TRH degradation rates vary widely between different animal species.
Biochem Pharmacol. 1981 Mar 15;30(6):619-22. doi: 10.1016/0006-2952(81)90134-9.
6
An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivo.
Biochem Pharmacol. 1980 Oct 1;29(19):2619-23. doi: 10.1016/0006-2952(80)90076-3.
7
The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat.
Endocrinology. 1984 Sep;115(3):1031-7. doi: 10.1210/endo-115-3-1031.
8
Prolyl endopeptidase.脯氨酰内肽酶
Life Sci. 1983 Nov 28;33(22):2149-57. doi: 10.1016/0024-3205(83)90285-0.
9
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
Drug Metab Rev. 1983;14(1):77-98. doi: 10.3109/03602538308991382.
10
Histidyl-proline diketopiperazine: its biological role as a regulatory peptide.组氨酰-脯氨酸二酮哌嗪:其作为调节肽的生物学作用。
Mol Cell Biochem. 1982 Jan 16;42(1):45-63. doi: 10.1007/BF00223538.